Fast, natural nasal congestion relief with the FDA‑cleared SONU Headband—drug‑free and backed by a 30‑day risk‑free guarantee. Breathe easy in minutes.
SoundHealth raises $12.25 million in Series A financing led by Shangbay Capital. The company says it will use the funding to accelerate personalized, FDA-cleared therapeutics for breathing and sleep disorders.
SoundHealth raises $12.25 million in Series A financing led by Shangbay Capital to accelerate growth of its non-invasive AI wearable business. The financing will support expansion of SONU, the company's FDA-cleared wearable product for nasal congestion and related respiratory conditions.
SoundHealth’s SONU Band is named to TIME’s Best Inventions of 2025 in the Health & Wellness category. The FDA-approved, drug-free wearable uses acoustic therapy to relieve nasal congestion and is the first FDA De Novo-authorized AI-enabled device for treating allergic and non-allergic rhinitis.
SoundHealth launched its first-ever medical-grade Android app for the FDA-approved SONU Band, which transforms a selfie into CT-accurate skeletal data to guide AI-driven, drug-free rhinitis treatment. The app expands access to millions of Android users with allergies and sinus issues.